XML 18 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Loss (unaudited) - USD ($)
shares in Millions, $ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Net sales $ 2,625 $ 2,490
Cost of sales 1,764 1,529
Gross margin 861 961
Selling, general and administrative expenses 703 729
Research and development expenses 140 120
Other operating income, net (40) (3)
Operating income 58 115
Interest expense, net 64 78
Other (income) expense, net 3 9
Income (loss) from continuing operations before income taxes (3) 46
Income tax expense (benefit) (67) 40
Income (loss) from continuing operations 64 6
Income (loss) from discontinued operations, net of tax 62 33
Net income (loss) 126 39
Net income attributable to noncontrolling interests included in continuing operations 0 0
Net income attributable to noncontrolling interests included in discontinued operations 0 2
Less: Comprehensive income attributable to noncontrolling interests 0 2
Net income (loss) attributable to Baxter stockholders $ 126 $ 37
Income (loss) from continuing operations per common share    
Income from continuing operations per common share, basic (in dollars per share) $ 0.13 $ 0.01
Income from continuing operations per common share, diluted (in dollars per share) 0.13 0.01
Income (loss) from discontinued operations per common share    
Income from discontinued operations per common share, basic (in dollars per share) 0.12 0.06
Income from discontinued operations per common share, diluted (in dollars per share) 0.12 0.06
Income (loss) per common share    
Basic (in dollars per share) 0.25 0.07
Diluted (in dollars per share) $ 0.25 $ 0.07
Weighted-average number of shares outstanding    
Basic (in shares) 512 508
Diluted (in shares) 514 510